Novo Nordisk said on Thursday it has identified a security incident in which certain information, including patient data from some clinical trials, was copied externally without authorization from its internal IT systems.
The company, maker of the blockbuster weight-loss drug Wegovy, said it has launched a probe with the assistance of external cybersecurity experts and is in contact with the relevant authorities.
Sign up here.
“The incident affected a limited amount… [1272 chars]
Source: Reuters | Published: 2026-06-11T15:45:22Z
Credit: Reuters
